Bispecific T-Cell Engager Delivered through Tissue Targeting LNP Demonstrated Potent Antitumor Effects on Both Hematological Malignancies and Solid Tumors

被引：0
|
作者：
Kai, Xin [1 ]
Zhang, Yixin [1 ]
Wei, Benjamin [1 ]
Tatang, Daniella [1 ]
Angus, Stu [1 ]
Jin, Caining [1 ]
Huang, Kun [1 ]
Huang, Changfeng [1 ]
Li, Haishan [1 ]
Brenner, Lou [1 ]
Xu, Qiaobing [1 ]
Zhang, Kate [1 ]
机构：
[1] Hopewell Therapeut Inc, Woburn, MA USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1273
引用
收藏
页码：606 / 606
页数：1
相关论文
共 42 条
  • [1] Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy
    Arvedson, Tara
    Bailis, Julie M.
    Britten, Carolyn D.
    Klinger, Matthias
    Nagorsen, Dirk
    Coxon, Angela
    Egen, Jackson G.
    Martin, Flavius
    ANNUAL REVIEW OF CANCER BIOLOGY, 2022, 6 : 17 - 34
  • [2] Looking ahead to CD3, T-cell engager bispecific antibodies for hematological malignancies
    Reed, Daniel R.
    Lum, Lawrence G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (08) : 761 - 772
  • [3] A novel bispecific T-cell engager for targeting ROR1 positive malignancies
    Gohil, S. H.
    Moscosso, S. R. Paredes
    Harrasser, M.
    Sorio, C.
    Davidoff, A. M.
    Nathwani, A. C.
    Della Peruta, M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A60 - A60
  • [4] Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V
    Lu, Changchang
    Zou, Lu
    Wang, Qiaoli
    Sun, Mengna
    Shi, Tianyu
    Xu, Shuang
    Meng, Fanyan
    Du, Juan
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (05): : 1424 - 1434
  • [5] Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager
    Xiao, Xinghui
    Cheng, Ying
    Zheng, Xiaodong
    Fang, Yuhang
    Zhang, Yu
    Sun, Rui
    Tian, Zhigang
    Sun, Haoyu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Arming oncolytic adenovirus with FAP-targeting bispecific T-cell engager to improve antitumor efficacy
    de Sostoa Pomes, J.
    Fajardo, C. A.
    Farrera Sal, M.
    Moreno, R.
    Arias-Badia, M.
    Rojas, L. A.
    Alemany, R.
    ANNALS OF ONCOLOGY, 2017, 28 : 18 - 18
  • [7] CEA TCB, a novel T-cell bispecific antibody with potent in vitro and in vivo antitumor activity against solid tumors
    Bacac, Marina
    Fauti, Tanja
    Colombetti, Sara
    Sam, Johannes
    Nicolini, Valeria
    Steinhoff, Nathalie
    Ast, Oliver
    Bruenker, Peter
    Hosse, Ralf
    Hofer, Thomas
    Moessner, Ekkehard
    Jaeger, Christiane
    Saro, Jose
    Karanikas, Vaios
    Klein, Christian
    Umana, Pablo
    CANCER RESEARCH, 2015, 75
  • [8] Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager (14, 1113303, 2023)
    Xiao, Xinghui
    Cheng, Ying
    Zheng, Xiaodong
    Fang, Yuhang
    Zhang, Yu
    Sun, Rui
    Tian, Zhigang
    Sun, Haoyu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager
    Wing, Anna
    Fajardo, Carlos Alberto
    Posey, Avery D., Jr.
    Shaw, Carolyn
    Da, Tong
    Young, Regina M.
    Alemany, Ramon
    June, Carl H.
    Guedan, Sonia
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (05) : 605 - 616
  • [10] Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors
    Wei, Min
    Zuo, Shuguang
    Chen, Zhimin
    Qian, Peng
    Zhang, Yenan
    Kong, Lingkai
    Gao, Honglan
    Wei, Jiwu
    Dong, Jie
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345